TFA Therapeutics (RAJAF) Inventory Average (2021 - 2023)

TFA Therapeutics has reported Inventory Average for 3 years, with the latest figure at $158919.0 in Q3 2023.

• On a quarterly basis, Inventory Average changed N/A year-over-year to $158919.0 in Q3 2023; TTM through Sep 2023 was $158919.0, a N/A change from a year earlier, with the FY2022 full-year figure at $396941.0, down 31.9% from the prior year.
• Inventory Average was $158919.0 for Q3 2023 at TFA Therapeutics, down from $396941.0 in the prior quarter.
• The five-year high for Inventory Average was $582881.0 in Q4 2021, with the low at $158919.0 in Q3 2023.
• Average Inventory Average over 3 years is $379580.3, with a median of $396941.0 recorded in 2022.
• The largest YoY upside for Inventory Average was 31.9% in 2022 against a maximum downside of 31.9% in 2022.
• Over 3 years, Inventory Average stood at $582881.0 in 2021, then plunged by 31.9% to $396941.0 in 2022, then tumbled by 59.96% to $158919.0 in 2023.
• The last three Inventory Average figures came in at $158919.0 (Q3 2023), $396941.0 (Q4 2022), and $582881.0 (Q4 2021), per Business Quant data.